Atlas Antibodies AB

https://www.atlasantibodies.com

LinkedIn: https://www.linkedin.com/company/atlas-antibodies

Atlas Antibodies was founded in 2006 as a start-up from the Human Protein Atlas project and has over the last 15 years successfully launched more than 60,000 products for protein research. The company was founded by researchers at the Royal Institute of Technology (KTH) in Stockholm and the Rudbeck Laboratory, Uppsala University in Uppsala to handle the production, marketing and sales of research tools developed by the Swedish-based Human Protein Atlas program. Headquartered in Stockholm, Sweden, Atlas Antibodies provides high-quality reagents for biomedical research, including polyclonal and monoclonal antibodies and QPrESTs. Earlier this year, Atlas Antibodies acquired UK-based HistoCyte Laboratories – a leading supplier of cell line controls for pathology applications, and Swiss-based evitria – an expert provider of antibody expression services. *

	Start	2006-01-01 established (s-off)
	Group	Atlas Antibodies (Group)
	Predecessor	University of Uppsala (Uppsala University)
	Industry	research antibody
	Industry 2	reagents (bio/biochemical)
	Person	Klæbel, Nille (Atlas Antibodies 202109– CEO before Philips Nordics + GSK + Sanofi + Novo Nordisk)
	Person 2	Jørgensen, Torben (Biotage 200604–201910 CEO before Affibody CEO before Karo Bio before Dako)

	Region	Bromma
	Country	Sweden
	Street	13 Voltavägen
	City	16869 Bromma
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Atlas Antibodies AB. (8/20/21). "Press Release: Atlas Antibodies AB Appoints Nille Klæbel as New CEO".

		Record changed: 2024-02-12